| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |